Difference in growth suppression and apoptosis induction of EGCG and EGC on human promyelocytic leukemia HL-60 cells

Archives of Pharmacal Research

Volumn 32, Issue 4, 2009, Pages 543-547

  Han, Dong Hoon ^a   Kim, Jeong Hee ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Apoptosis; Bcl 2; Caspase 3; EGC; EGCG; Growth suppression

Indexed keywords

CASPASE 3; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IC 50; PROTEIN EXPRESSION; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CATECHIN; CELL PROLIFERATION; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; LEUKEMIA, PROMYELOCYTIC, ACUTE; PROTO-ONCOGENE PROTEINS C-BCL-2; TIME FACTORS;

EID: 65549167405     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1410-z     Document Type: Article

References (22)

1. B. B. Aggarwal S. Shishodia 2006 Molecular targets of dietary agents for prevention and therapy of cancer Biochem. Pharm. 71 1397 1421
2. S. Ahmed A. Rahman A. Hanain M. Lalonde V. M. Goldberg T. M. Haqqi 2002 Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1β-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes Free Radic. Biol. Med. 33 1097 1105
3. A. M. Bode Z. Dong 2003 Signal transduction pathways: Targets for green and black tea polyphenols J. Biochem. Mol. Biol. 36 66 77 (Pubitemid 36836258)
4. T. Dorai B. B. Aggarwal 2004 Role of chemopreventive agents in cancer theraphy Cancer Lett. 215 129 140 (Pubitemid 39370030)
5. H. Fujiki M. Suganuma K. Imai K. Nakachi 2002 Green tea: cancer preventive beverage and/or drug Cancer Lett. 188 9 13 (Pubitemid 35292323)
6. B. B. Hafeez S. Ahmed N. Wang S. Gupta A. Zhang T. M. Haqqi 2006 Green tea polyphenols-induced apoptosis in human osteosarcoma SAOS-2 cells involves a caspase-dependent mechanism with down regulation of nuclear factor-βB Toxicol. Appli. Pharmacol. 216 11 19 (Pubitemid 44402629)
7. M. B. Hansen S. E. Nielsen K. Berg 1989 Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill J. Immonol. Methods 12 203 210 (Pubitemid 19132276)
8. J. F. Hernaez M. Xu R. H. Dashwood 1998 Antimutagenic activity of tea towards 2 hydroxyamino-3-methylimidazo[4,5-f] quiolone:effect of tea concentration and brew time on electrophile scarvenging Mut. Res. 402 299 306 (Pubitemid 28440286)
9. T. C. Hour Y. C. Liang I. S. Chu J. K. Lin 1999 Inhibition of eleven mutagens by various tea extracts, (-) epigallocatechin-3-gallate, gallic acid and caffeine Food. Chem. Toxicol. 37 569 579 (Pubitemid 29438557)
10. J. F. Kerr C. M. Winterford B. V. Harmon 1994 Apoptosis: Its significance in cancer and cancer therapy Cancer 73 2013 2026 (Pubitemid 24107952)
11. S. E. Lee H.-T. Shin H. J. Hwang J. H. Kim 2003 Antioxidant activity of extracts from Alpinia katsumadai seed Phytother. Res. 17 1041 1047 (Pubitemid 37351577)
12. J. Mimito K. Kiura K. Matsuo T. Yoshino I. Takata H. Ueoka M. Kataoka M. Harada 2000 (-)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice Carcinogenesis 21 915 919 (Pubitemid 30265134)
13. H. Mukhtar N. Ahmad 2000 Tea polyphenols: prevention of cancer and optimizing health Am. J. Clin. Nutr. 71 1698S 1702S (Pubitemid 30396266)
14. K. Neukam N. Pastor F. Cortés 2008 Tea flavanols inhibit cell growth and DNA topoisomerase II activity and induce endoreduplication in cultured Chinese hamster cells Mut. Res. 654 8 12
15. D. W. Nicholson A. Ali N. A. Thornberry J. P. Vaillancourt C. K. Ding M. Gallant Y. Gareau P. R. Griffin M. Labelle Y. A. Lazebnik N. A. Mundau S. M. Raju M. E. Smulson T. T. Yamin V. L. Yu D. K. Miller 1995 Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 376 37 43
16. 2/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells Biochem. Pharmacol. 62 1439 1447 (Pubitemid 33145287)
17. J. C. Reed 1998 Bcl-2 family proteins Oncogene 17 3225 3226 (Pubitemid 29043975)
18. X. Shi S. S. Leonard M. Ding V. Vallyathan V. Castranova Y. Rojanasaki Z. Dong 2000 Antioxidant properties of (-)-epigallocatechin-3-gallate and its inhibition of Cr(VI)-induced DNA damage and Er(IV)0 or TPA-stimulated NF-kappaB activation Mol. Cell. Biochem 206 125 132 (Pubitemid 30246514)
19. M. Suganuma S. Okabe N. Sueoka E. Sueoka S. Matsuyama K. Imai K. Nakachi H. Fujiki 1999 Green tea and cancer chemoprevention Mutat. Res. 428 339 344 (Pubitemid 29389704)
20. D. Vergote C. Cren-Olivé V. Chopin R.-A. Toillon C. Rolando H. Hondermarck X. L. Bourhis 2002 (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts Breast Cancer Res. Treat. 76 195 201 (Pubitemid 35335209)
21. C. S. Yang P. Maliakal X. Meng 2002 Inhibition of carcinogenesis by tea Annu. Rev. Pharmacol., Toxicol. 42 25 54 (Pubitemid 34160518)
22. N. T. Zaveri 2006 Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications Life Sci. 78 2073 2080